Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-04-24 | The current members of the Audit Committee are Raymond C. Carnahan, Jr. (Chairman), Lyle A. Hohnke and Herbert H. McDade, Jr. Mr. Hohnke's term as a director expires at the Annual Meeting and he is not standing for re-election. ... The Compensation Committee's current members are Herbert H. McDade, Jr. (Chairman), Raymond C. Carnahan, Jr. and Lyle A. Hohnke. Mr. Hohnke's term as a director expires at the Annual Meeting and he is not standing for re-election. |
| Filing Date | Source Excerpt |
|---|---|
| 2012-04-16 | Lyle A. Hohnke - Director of the Company. Includes 475,000 shares Mr. Hohnke may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan. |
| 2013-04-26 | Lyle A. Hohnke - Independent director of the Company. Includes 517,500 shares Mr. Hohnke may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan. |
| 2014-05-02 | Lyle A. Hohnke - Independent director of the Company. Includes 551,665 shares Mr. Hohnke may acquire upon the exercise of stock options approved by the Board and issued under the Companys 2002 Long-Term Incentive Plan and 2013 Equity Incentive Plan. |
| 2014-10-01 | Dr. Hohnke holds Ph.D. and M.A. degrees from the University of Oregon and an M.B.A. degree from the Hartford Graduate Institute at Rensselaer Polytechnic Institute. His experience is in healthcare and venture capital. |
Data sourced from SEC filings. Last updated: 2025-12-06